| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/26/2008 | EP1903058A2 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903055A2 Recombinant haemophilus influenzae adhesin proteins |
| 03/26/2008 | EP1903054A2 Pharmaceutical compound containing a stabilised mRNA which is optimised for translation in its coded areas |
| 03/26/2008 | EP1902732A1 Prophylactic/therapeutic agent for her2-expressing cancer |
| 03/26/2008 | EP1902729A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
| 03/26/2008 | EP1902727A1 Vaccines comprising truncated HBC core protein plus saponin-based adjuvants |
| 03/26/2008 | EP1902726A2 Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 03/26/2008 | EP1902320A2 Pretreatment of a biological sample from an autoimmune disease subject |
| 03/26/2008 | EP1902318A1 Methods for identifying fzd8 modulators and the use of such modulators for treating osteoarthritis |
| 03/26/2008 | EP1901774A2 Multivalent entrain-and-amplify immunotherapeutics for carcinoma |
| 03/26/2008 | EP1901768A1 Methods of modulating il-23 activity; related reagents |
| 03/26/2008 | EP1620072B1 Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 03/26/2008 | EP1527089B1 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 03/26/2008 | EP1465911B1 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 03/26/2008 | EP0879060B1 Vaccines against varicella zoster virus gene 63 product |
| 03/26/2008 | EP0871482B1 Recombinant vesiculoviruses and their uses |
| 03/26/2008 | EP0764029B2 Proteinaceous adjuvants |
| 03/26/2008 | CN101151278A CD20 antibody variants and uses thereof |
| 03/26/2008 | CN101151277A Anti-interferon gamma antibodies and methods of use thereof |
| 03/26/2008 | CN101151274A ROR alpha for promoting the induction of Bmal1 expression |
| 03/26/2008 | CN101151061A Coated microprojections having reduced variability and method for producing same |
| 03/26/2008 | CN101151049A Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 03/26/2008 | CN101151020A Adjuvanting material |
| 03/26/2008 | CN101148678A Human papilloma virus vaccine and preparation method thereof |
| 03/26/2008 | CN101148478A Streptavidin-tumour putrescence factor alpha fusion protein |
| 03/26/2008 | CN101148477A Streptavidin-interleukins 2 fusion protein |
| 03/26/2008 | CN101148475A Human breast cancer resisting recombination immunotoxin M4G3/ScFv-PE40 |
| 03/26/2008 | CN101148474A Human resource vessel endothelium growth factor monoclonal antibody and preparation method thereof |
| 03/26/2008 | CN101148471A Buckwheat allergen, IgE kit thereof, preparation method and using method for the same |
| 03/26/2008 | CN101147815A HIV (individual) vaccine making machine |
| 03/26/2008 | CN101147807A Substances for preventing and treating autoimmune diseases |
| 03/26/2008 | CN101147804A Anti Toll-like receptor 2 antibody anti pulmonary fibrosis use |
| 03/26/2008 | CN101147803A Anti Toll-like receptor 2 antibody inhibiting tumor metastasis use |
| 03/26/2008 | CN100376599C Recombining single chained three specific antibodies of anti CCA, anti CD 3, anti CD 28 through genetic engineering |
| 03/26/2008 | CN100376290C Antigenic peptides derived from telomerase |
| 03/26/2008 | CN100376288C Improvement of T cell mediated immunity |
| 03/25/2008 | US7349811 Designing primers which target and clone preferential gene sequences |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348423 Nucleic acids encoding fusion peptides |
| 03/25/2008 | US7348422 Fused protein, gene therefor, recombinant vector, recombinant virus, and its use |
| 03/25/2008 | US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/25/2008 | US7348413 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferfative disorders; immunotherapy; immunodiagnostics |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348405 PRO10274 polypeptides |
| 03/25/2008 | US7348305 Inhibitor of cardiac tachyarrhythmias |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348136 Immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics; veterinary medicine |
| 03/25/2008 | US7348015 Antigen modified cancer cell vaccines for cancer therapy |
| 03/25/2008 | US7348014 Anticancer agents; gene therapy; trimers; host cells; genomes |
| 03/25/2008 | US7348012 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |
| 03/25/2008 | US7348011 Hepatitis C virus vaccine |
| 03/25/2008 | US7348010 Contains at least one peptide with a length of 9 to 25 amino acids and a sequence as occurs in extracellular doamin of HER-2/neu protein, and the peptide or functional variants conjugated to an immunogenic carrier |
| 03/25/2008 | US7348009 Recombinant allergen with reduced enzymatic activity |
| 03/25/2008 | US7348008 Ricin-like toxins for treatment of cancer |
| 03/25/2008 | US7348007 Mage C2 antigenic peptides and uses thereof |
| 03/25/2008 | US7348006 histidine to improve pH stability, adjuvant adsorption, and reduce antigen hydrolysis in vaccines using aluminum salt(s) |
| 03/25/2008 | US7348005 Administering type V collagen |
| 03/25/2008 | US7348004 Immunoglobulin chimeric monomer-dimer hybrids |
| 03/25/2008 | US7348003 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders |
| 03/25/2008 | US7348002 peptides and monoclonal antibodies used as blocking agents, that disrupt the interaction between collagen and integrins; prophylaxis of inflammatory diseases |
| 03/25/2008 | US7348001 Protein that includes a heavy chain immunoglobulin variable domain sequence and a light chain immunoglobulin variable domain sequence; the protein ligand binds to Tie1 ectodomain, a receptor tyrosine kinase protein that includes a transmembrane domain; use in modulating angiogenesis |
| 03/25/2008 | US7347996 Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2327522C Incorporation of active substances in carrier matrixes |
| 03/25/2008 | CA2115579C Ryegrass pollen allergen |
| 03/20/2008 | WO2008034121A2 Parasite vaccine |
| 03/20/2008 | WO2008034076A2 Cyclophosphamide in combination with immune therapeutics |
| 03/20/2008 | WO2008034074A2 Cyclosphosphamide in combination with anti-idiotypic vaccines |
| 03/20/2008 | WO2008033966A2 Alphavirus replicon particles matched to protein antigens as immunological adjuvants |
| 03/20/2008 | WO2008033878A2 Enhanced local interconnects employing ferroelectric electrodes |
| 03/20/2008 | WO2008033500A2 Carbohydrate-based vaccines for hiv |
| 03/20/2008 | WO2008033495A2 Method for detecting and treating skin disorders |
| 03/20/2008 | WO2008033374A2 Ocl-2a3 compositions and uses thereof |
| 03/20/2008 | WO2008033105A1 Hemagglutinin antibody and uses thereof |
| 03/20/2008 | WO2008033041A1 Cancer treatment |
| 03/20/2008 | WO2008032876A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 03/20/2008 | WO2008032833A1 Antibody having enhanced adcc activity and method for production thereof |
| 03/20/2008 | WO2008032796A1 Novel vaccine for dog |
| 03/20/2008 | WO2008032712A1 Monoclonal antibody and use thereof |
| 03/20/2008 | WO2008032153A2 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 03/20/2008 | WO2008032073A2 Novel nematode protein and its use in producing anthelminthic agents and vaccines |
| 03/20/2008 | WO2008031878A1 A composition for therapy and/or for prophylaxis of hbv-infections and hbv-mediated diseases |
| 03/20/2008 | WO2008031842A1 Inhibitors of gpr87 for cancer therapy |
| 03/20/2008 | WO2008031626A1 Treatment of multiple sclerosis (ms) with campath-1h |
| 03/20/2008 | WO2008031531A1 Tumor therapy with a combination of anti-her2 antibodies |
| 03/20/2008 | WO2008031331A1 A recombinant adenovirus target-oriented coexpressing human p53 and p53aip1 |
| 03/20/2008 | WO2008031126A1 Multi-component tumour vaccine |
| 03/20/2008 | WO2008000261A3 Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
| 03/20/2008 | WO2007149861A3 Soft tissue repair and regeneration using stem cell products |
| 03/20/2008 | WO2007146024A3 Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| 03/20/2008 | WO2007141043A3 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 03/20/2008 | WO2007140505A3 Vaccine carrier |
| 03/20/2008 | WO2007137591A3 Hiv vaccine |
| 03/20/2008 | WO2007135224B1 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products |
| 03/20/2008 | WO2007134350A3 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
| 03/20/2008 | WO2007132480A3 A composition useful as a vaccine |
| 03/20/2008 | WO2007130453A3 Non-natural amino acid substituted polypeptides |
| 03/20/2008 | WO2007127506A3 Anti-ephrinb2 antibodies and methods using same |